In an interview with Targeted Oncology during the 2019 Kidney Cancer Research Summit, Dr Wayne Marasco, professor of medicine at Harvard Medical School, and principal investigator of cancer immunology and virology at Dana-Farber Cancer Institute, discussed engineering CAR T cells for the treatment of solid tumours, in particular renal cell carcinoma (RCC).

It is hypothesised that the use of CAR T-cell therapy may revolutionise the treatment of RCC, as already seen in blood cancers. However, challenges still exist with applying CAR T cells to solid tumours, RCC, in particular.

Read Dr Marasco’s interview with Targeted Oncology here